Product Number |
ARP39920_P050 |
Product Page |
www.avivasysbio.com/mier3-antibody-middle-region-arp39920-p050.html |
Name |
MIER3 Antibody - middle region (ARP39920_P050) |
Protein Size (# AA) |
549 amino acids |
Molecular Weight |
61kDa |
NCBI Gene Id |
166968 |
Host |
Rabbit |
Clonality |
Polyclonal |
Concentration |
0.5 mg/ml |
Gene Full Name |
Mesoderm induction early response 1, family member 3 |
Alias Symbols |
DKFZP781I1119, DKFZp686L09111, DKFZp781G1119, DKFZp781I1119, FLJ35954 |
Peptide Sequence |
Synthetic peptide located within the following region: MNMCSEESERPAKRLKMGIAVPESFMNEVSVNNLGVDFENHTHHITSAKM |
Product Format |
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
Reference |
Mehrle,A., Nucleic Acids Res. 34 (DATABASE ISSUE), D415-D418 (2006) |
Description of Target |
MIER3 is a transcriptional repressor. |
Protein Interactions |
SUMO1; HDAC1; HDAC2; |
Reconstitution and Storage |
For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles. |
Datasheets/Manuals |
Printable datasheet for anti-MIER3 (ARP39920_P050) antibody |
Blocking Peptide |
For anti-MIER3 (ARP39920_P050) antibody is Catalog # AAP39920 (Previous Catalog # AAPP10234) |
Immunogen |
The immunogen is a synthetic peptide directed towards the middle region of human MIER3 |
Uniprot ID |
Q7Z3K6-3 |
Protein Name |
Mesoderm induction early response protein 3 |
Protein Accession # |
NP_689835 |
Purification |
Affinity Purified |
Nucleotide Accession # |
NM_152622 |
Tested Species Reactivity |
Human |
Gene Symbol |
MIER3 |
Predicted Species Reactivity |
Human, Mouse, Rat, Cow, Dog, Horse, Pig, Rabbit, Yeast |
Application |
WB |
Predicted Homology Based on Immunogen Sequence |
Cow: 100%; Dog: 100%; Horse: 100%; Human: 100%; Mouse: 100%; Pig: 100%; Rabbit: 100%; Rat: 100%; Yeast: 100% |
Image 1 | Human COLO205
| WB Suggested Anti-MIER3 Antibody Titration: 0.2-1 ug/ml ELISA Titer: 1:62500 Positive Control: COLO205 cell lysate |
|
|